Back to medications
Medication monograph

lumasiran

Small Interfering RNA (siRNA) TherapeuticsRNA Interference AgentsMetabolic Modifying Agents

Clinical reference

Product monograph

OXLUMO- lumasiran injection, solution

Brands & formulations

Family members

OXLUMO

Marketed
94.5 MGSUBCUTANEOUSSOLUTION[ "lumasiran (lumasiran sodium)" ]
Product monograph

Classification

Chemical class
Small Interfering RNA (siRNA) Therapeutics
Clinical class
RNA Interference Agents, Metabolic Modifying Agents